DSIP (Delta Sleep-Inducing Peptide) offers targeted sleep architecture improvement through direct neural modulation, while melatonin regulates circadian rhythm through hormone receptor activation
Many users combine approaches: daily topical application for consistent follicle exposure plus periodic injections for systemic support
CagriSema vs Comparators Feature Receptor targets CagriSema Amylin/calcitonin + GLP-1 Tirzepatide (Zepbound) GIP + GLP-1 Semaglutide alone (Wegovy) GLP-1 Cagrilintide alone Amylin/calcitonin (DACRA) Feature Dosing frequency CagriSema Once weekly Tirzepatide (Zepbound) Once weekly Semaglutide alone (Wegovy) Once weekly Cagrilintide alone Once weekly Feature Maintenance dose CagriSema 2.4 mg + 2.4 mg Tirzepatide (Zepbound) Up to 15 mg Semaglutide alone (Wegovy) 2.4 mg Cagrilintide alone 2.4 mg (in REDEFINE arms) Feature Headline weight loss CagriSema 20.4% at 68 wks (REDEFINE 1, treatment-policy) Tirzepatide (Zepbound) Up to 22.5% at 72 wks (SURMOUNT-1, 15 mg arm) Semaglutide alone (Wegovy) 14.9% at 68 wks (REDEFINE 1 reference arm) Cagrilintide alone 11.5% at 68 wks (REDEFINE 1 reference arm) Feature FDA status (June 2026) CagriSema NDA filed Dec 2025
At Vitality Health SFL, we see first hand how well these targeted therapies can help our clients get back on their feet faster
TB-500 (Thymosin Beta-4): Systemic Regeneration Mechanism of Action: TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring peptide in almost all human and animal cells
The wolverine peptide is the informal name for a combination stack of BPC-157 (Body Protection Compound-157) and TB-500 (Thymosin Beta-4)
